Previous Close | 82.17 |
Open | 82.33 |
Bid | 80.88 x 500 |
Ask | 80.96 x 500 |
Day's Range | 80.90 - 83.09 |
52 Week Range | 76.02 - 99.56 |
Volume | |
Avg. Volume | 1,533,565 |
Market Cap | 15.355B |
Beta (5Y Monthly) | 0.32 |
PE Ratio (TTM) | 76.33 |
EPS (TTM) | 1.06 |
Earnings Date | Apr 24, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 110.10 |
Insightful Analysis of Biomarin Pharmaceutical Inc's Strengths, Weaknesses, Opportunities, and Threats
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript April 24, 2024 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.71, expectations were $0.6. BioMarin Pharmaceutical Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name […]
BioMarin Pharmaceutical ( NASDAQ:BMRN ) First Quarter 2024 Results Key Financial Results Revenue: US$648.8m (up 8.8...